Transcode Therapeutics, Inc. - 8-K Filing
Transcode Therapeutics announced its 2026 annual meeting of stockholders will be held on July 2, 2026, with a record date of May 28, 2026. The company is providing updated deadlines for submitting shareholder proposals and director nominations due to the change in the meeting date by more than 30 days from the prior year's meeting. (Items: 5.08 Shareholder Director Nominations)
Tickers: $RNAZ